Top Back to top

Analysis of alloSCT in MDS and 5q-chromosomal abnormalities

Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42205536
Type of Stem Cell Treatment:
 
Diseases:
Myelodysplastic (MDS) or MDS/MPN
Short title:
 
Primary objective:
 
Key inclusion criteria:
>18years old; MDS 5q-; alloSCT
Country:
 
Principal investigator:
Laurent Garderet
EBMT Study coordinator:
Erica Knödler